PPM1D
protein-codingprotein phosphatase, Mg2+/Mn2+ dependent 1D, the group of Protein phosphatases, Mg2+/Mn2+ dependent
Gene summary
The protein encoded by this gene is a member of the PP2C family of Ser/Thr protein phosphatases. PP2C family members are known to be negative regulators of cell stress response pathways. The expression of this gene is induced in a p53-dependent manner in response to various environmental stresses. While being induced by tumor suppressor protein TP53/p53, this phosphatase negatively regulates the activity of p38 MAP kinase, MAPK/p38, through which it reduces the phosphorylation of p53, and in turn suppresses p53-mediated transcription and apoptosis. This phosphatase thus mediates a feedback regulation of p38-p53 signaling that contributes to growth inhibition and the suppression of stress induced apoptosis. This gene is located in a chromosomal region known to be amplified in breast cancer. The amplification of this gene has been detected in both breast cancer cell line and primary breast tumors, which suggests a role of this gene in cancer development. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~66.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0016419
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0044318
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0000508
Submitter: ClinGen
The *PPM1D* gene encodes a member of the PP2C family of serine/threonine protein phosphatases which are negative regulators of cell stress response pathways. Association between *PPM1D* variants and autosomal dominant syndromic intellectual disability (Jansen-de Vries syndrome) was first reported in 2017 (Jansen et al., PMID: 28343630). Since then, at least 20 truncating variants, most of which are *de novo*, have been reported in individuals with intellectual disability and/or developmental delay, hypotonia, behavioral problems including autism spectrum disorder, high pain threshold, and facial dysmorphism (PMIDs: 28343630, 29758292, 30795918, 30979967, 31916397, 32399599). All the variants are located in the last or penultimate exon and are expected to escape nonsense-mediated mRNA decay, which is supported by the presence of truncated *PPM1D* transcripts in patient-derived cells (PMID: 28343630). In addition, these cells showed a cell-growth disadvantage after exposure to ionizing radiation, suggesting a possible effect on the stress-response pathway (PMID: 28343630). *PPM1D* has a pLI of 0 in gnomAD (v2.1.1), with 49 observed truncating variants. Mosaic C-terminal truncating *PPM1D* variants in blood are associated with clonal hematopoiesis during aging and cancer therapy (PMID: 34963005). This suggests that some of the truncating variants in gnomAD, many of which exhibit allelic imbalance, may represent somatic mosaicism. In summary, *PPM1D* is definitively associated with autosomal dominant syndromic intellectual disability. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on February 15, 2022 (SOP Version 8).
Inheritance Pattern: Unknown
Disease ID:MONDO:0016419
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0044318
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0044318
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0044318
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PPM1D variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003620.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 73 | 3 | 77 | ||
| missense | 1 | 126 | 46 | 5 | 178 | |
| nonsense | 8 | 14 | 9 | 31 | ||
| start loss | 0 | |||||
| frameshift | 24 | 41 | 28 | 93 | ||
| splice donor/acceptor (+/-2bp) | 1 | 4 | 5 | |||
| Total | 32 | 57 | 168 | 119 | 8 | 384 |
Highest pathogenic variant AF is 0.00001920675
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003611.1 | 6 | MANE Select | |
| Ensembl | ENSP00000306682.2 | 6 | MANE Select | |
| Ensembl | ENSP00000376720.3 | 6 | Standard | |
| Ensembl | ENSP00000486573.2 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- p53 signaling pathway - Homo sapiens (human)
- ATM Signaling Network in Development and Disease
- Transcriptional regulation by RUNX2
- Gene expression (Transcription)
- Generic Transcription Pathway
Biological Process
- G2/M transition of mitotic cell cycle
- DNA methylation
- chromatin silencing
- transcription initiation from RNA polymerase II promoter
- protein phosphorylation
Molecular Function
- protein serine/threonine kinase activity
- protein serine/threonine phosphatase activity
- magnesium-dependent protein serine/threonine phosphatase activity
- protein binding
- metal ion binding
Cellular Component
- nucleus
- nucleoplasm
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000305921
- Coding exons
- 6
- Length
- 64306
- Individuals with no LoFs
- 125706
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 42
- Defined
- 125748
- p
- 0.000167
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.70 | 200 | 340 | 0.588 | 0.0000170 | 3920 |
| Missense (PolyPhen) | 37 | 126.13 | 0.29334 | 1383 | ||
| Synonymous | 1.22 | 104 | 121 | 0.859 | 0.00000576 | 1221 |
| Loss of Function | 1.17 | 20 | 26.5 | 0.754 | 0.00000168 | 265 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.00027 | 0.00026 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in the negative regulation of p53 expression (PubMed:23242139). Required for the relief of p53-dependent checkpoint mediated cell cycle arrest. Binds to and dephosphorylates 'Ser-15' of TP53 and 'Ser-345' of CHEK1 which contributes to the functional inactivation of these proteins (PubMed:15870257, PubMed:16311512). Mediates MAPK14 dephosphorylation and inactivation (PubMed:21283629). Is also an important regulator of global heterochromatin silencing and critical in maintaining genome integrity (By similarity). {ECO:0000250|UniProtKB:Q9QZ67, ECO:0000269|PubMed:15870257, ECO:0000269|PubMed:16311512, ECO:0000269|PubMed:21283629, ECO:0000269|PubMed:23242139}.;
- Disease
- DISEASE: Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold (IDDGIP) [MIM:617450]: An autosomal dominant neurodevelopmental disorder characterized by mild to severe intellectual disability, psychomotor developmental delay, speech delay, and behavioral manifestations including attention deficit-hyperactivity disorder, autism and anxiety disorders. Most patients have variable additional features, including feeding and gastrointestinal difficulties, high pain threshold, hypersensitivity to sound, hypotonia, broad-based gait, and dysmorphic features, including mild facial abnormalities, strabismus, and small hands and feet. {ECO:0000269|PubMed:28343630}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:23242139}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:23242139}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.273
Intolerance Scores
- LoFtool
- 0.835
- RVIS EVS
- -0.34
- RVIS percentile EVS
- 30.37
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- E
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.907
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |